Panacea Biotec has informed that Dr. Aditya Narain Saksena, Non Executive Independent Director of the Company has resigned from the directorship of the Company vide his letter dated August 20, 2015 due to his ill health and that of his wife and accordingly he ... Money Control, 2 weeks ago
Panacea Biotec announces resignation of director - Business Standard, 2 weeks ago
Panacea Biotec informs about Outcome of Board Meeting - Finalaya.com, 1 month ago
1 images for "panacea biotec"
The stock dipped 14% to Rs 137 after the company reported a net loss of Rs 36.90 crore in the June quarter as against Rs 23.54 crore in the year-ago quarter. SI Reporter | Mumbai August 14, 2015 Last Updated at 13:02 IST Shares of Panacea Biotec have tanked ...Business Standard, 2 weeks ago
DoP rejects Panacea Biotec's review plea against price revision of 'amphotericin B injection (50 mg)'
The department of pharmaceuticals (DoP) has rejected the review application of Panacea Biotec against fixation/revision of retail price of scheduled medicine 'amphotericin B injection (50 mg)' by the national drug regulator National Pharmaceutical ...PharmaBiz, 1 month ago
The pharmaceutical companies in India, particularly the homegrown players, are yet to catch up with the usage of digital media in terms of presence and engagement even as the healthcare practitioners are using internet as a prominent tool to access ...Smart Investor, 1 month ago
Research and Markets (http://www.researchandmarkets.com/research/75dq35/diphtheria) has announced the addition of the "Diphtheria - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic ...Individual.com, 1 month ago Haemophilus Influenzae Type b Infections Therapeutics Pipeline Review, H1 2015 - 11 Companies & 16 Drug Profiles Individual.com, 1 month ago Research and Markets: Diphtheria Therapeutics Pipeline Report 2015 - 14 Companies & 21 Drug Profiles Reuters, 1 month ago RESEARCH AND MARKETS : Diphtheria Therapeutics Pipeline Report 2015 - 14 Companies & 21 Drug Profiles 4 Traders, 1 month ago
Investments in shares of pharmaceutical companies is considered to be relatively safe as compared to other industry segments in the country, but in recent years that scenario has changed dramatically. Scrips of quite a few pharma companies are ...PharmaBiz, 1 month ago
Diphtheria Pipeline Products and Comparative Analysis with Company Profiles Research Report Available at RnRMarketResearch.com
PRWeb The report "Neutropenia - Pipeline Review, H1 2015" provides comparative analysis on the therapeutic development for Neutropenia. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and ...Town Hall, 1 month ago Psoriatic Arthritis Therapeutic Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com CEOWorld Magazine, 1 month ago
Research and Markets has announced the addition of the "Psoriatic Arthritis - Pipeline Review, H1 2015" report to its offerings. In a release, Research and Markets noted that report highlights include: This report provides comprehensive ...Individual.com, 1 month ago Research and Markets Adds Report: Japanese Encephalitis - Pipeline Review, H1 2015 Individual.com, 2 months ago
on your WebpageAdd Widget >Get your members hooked!